Patients with older age (>65 years), HBV or HCV infection, liver cirrhosis, higher AFP level (>20 ng/mL), or larger tumor size (>5 cm) had shorter survival (p < 0.01; Table 4). This evidence concerns the gene AFP and cirrhosis of liver.